Department Of Medicine
-
Study seeks to expand treatment options for rare airway disease
Idiopathic subglottic stenosis is an unexplained narrowing of the windpipe just below the vocal cords. The disease is progressive, slowly affecting the patient’s ability to breathe, and can be fatal due to airway obstruction if left untreated. Read MoreJun 14, 2019
-
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology. Read MoreJun 14, 2019
-
Mouth health and colorectal cancer
Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC. Read MoreJun 6, 2019
-
Probing H. pylori cancer protein
Timothy Cover, john Loh and colleagues have identified how a certain type of mutation influences the risk of premalignant and malignant changes in the stomach. Read MoreFeb 15, 2019
-
New target for chronic kidney disease
Craig Brooks and colleagues have identified a mechanism of kidney fibrosis progression, suggesting a potential new angle for treating chronic kidney disease. Read MoreJan 31, 2019
-
In utero antibiotics and obesity risk
Exposure to antibiotics during pregnancy does not raise the risk of obesity in children. Read MoreJan 31, 2019
-
Lindsley named fellow of National Academy of Inventors
Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors. Read MoreJan 4, 2019
-
Philip’s liver cancer research receives V Foundation support
The grant will support Mary Philip's research to develop an organoid model — a miniature cell model of a functioning organ — of the liver to enable three-dimensional observation of immune-cancer interactions at the single-cell level at the earliest stages of cancer development. Read MoreDec 13, 2018
-
Immunotherapies linked to specific heart complications
In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have identified several of the conditions that arise and have determined that they usually appear early in treatment. Read MoreNov 16, 2018
-
Probing the pathology of impaired cognition
A new link between a support protein within the brain's white matter and known Alzheimer's biomarkers discovered by Angela Jefferson and colleagues bring researchers a step toward earlier and more precise detection of neuropathology underlying cognitive impairment that may lead to new targeted therapies Read MoreOct 26, 2018
-
Novel genetic study sheds new light on risk of heart attack
Loss of a protein that regulates mitochondrial function can greatly increase the risk of a heart attack, report Eric Gamazon, Sandra Zinkel and graduate students Christie Salisbury-Ruf and Clinton Bertram in new research. Read MoreOct 11, 2018
-
Stretch, inflammation and hypertension
New research by David Harrison and colleagues sheds light on how changes in mechanical forces in the aorta enhance immune cell activation thus promoting hypertension. Read MoreOct 4, 2018
-
Study reveals new targets to inhibit pulmonary fibrosis
An international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease. Read MoreOct 4, 2018
-
Cancer Moonshot award to help map tumor progression
A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States. Read MoreSep 27, 2018
-
Diabetes drug may prevent liver cancer
A new study by Harvey Murff finds that diabetics who take metformin have lower rates of liver cancer than those who take other diabetes drugs. Read MoreSep 21, 2018
-
New histoplasmosis risk map
Stephen Deppen and colleagues have developed an updated map showing new areas of increased risk for a common lung infection. Read MoreSep 21, 2018
-
Study tracks incidence, timing of immunotherapy-related deaths
Researchers led by melanoma researcher Douglas Johnson have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies. Read MoreSep 13, 2018
-
Research reveals link between immunity, diabetes
An immune cell called CD8+ is supposed to attack disease, but it can also contribute to inflammation, which can lead to insulin resistance and type 2 diabetes. Read MoreSep 13, 2018
-
Using light to fight GVHD
Vanderbilt researchers have discovered new insights into the treatment of chronic graft-versus-host-disease, a complication of bone marrow and stem cell transplants. Read MoreAug 30, 2018
-
A new target for lung cancer
Xiangming Ji, Pierre Massion and colleagues have discovered that blocking the transporter protein xCT could slow the progression of non-small cell lung cancer. Read MoreAug 17, 2018